JP2006523704A5 - - Google Patents

Download PDF

Info

Publication number
JP2006523704A5
JP2006523704A5 JP2006510018A JP2006510018A JP2006523704A5 JP 2006523704 A5 JP2006523704 A5 JP 2006523704A5 JP 2006510018 A JP2006510018 A JP 2006510018A JP 2006510018 A JP2006510018 A JP 2006510018A JP 2006523704 A5 JP2006523704 A5 JP 2006523704A5
Authority
JP
Japan
Prior art keywords
alkyl
group
substituted
substituents
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006510018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523704A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011463 external-priority patent/WO2004094371A2/en
Publication of JP2006523704A publication Critical patent/JP2006523704A/ja
Publication of JP2006523704A5 publication Critical patent/JP2006523704A5/ja
Pending legal-status Critical Current

Links

JP2006510018A 2003-04-17 2004-04-14 ケモカイン受容体活性ヘテロサイクリックシクロペンチルテトラヒドロイソキノリンおよびテトラヒドロピリドピリジンのモジュレーター Pending JP2006523704A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46367303P 2003-04-17 2003-04-17
PCT/US2004/011463 WO2004094371A2 (en) 2003-04-17 2004-04-14 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

Publications (2)

Publication Number Publication Date
JP2006523704A JP2006523704A (ja) 2006-10-19
JP2006523704A5 true JP2006523704A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=33310806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006510018A Pending JP2006523704A (ja) 2003-04-17 2004-04-14 ケモカイン受容体活性ヘテロサイクリックシクロペンチルテトラヒドロイソキノリンおよびテトラヒドロピリドピリジンのモジュレーター

Country Status (6)

Country Link
EP (1) EP1622916A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006523704A (cg-RX-API-DMAC7.html)
CN (1) CN100384856C (cg-RX-API-DMAC7.html)
AU (1) AU2004232939A1 (cg-RX-API-DMAC7.html)
CA (1) CA2521625A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004094371A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598243B2 (en) 2003-04-17 2009-10-06 Merck & Co., Inc. Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
CA2521625A1 (en) * 2003-04-17 2004-11-04 Merck & Co., Inc. Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
US8067415B2 (en) 2005-11-01 2011-11-29 Millennium Pharmaceuticals, Inc. Compounds useful as antagonists of CCR2
US8067457B2 (en) 2005-11-01 2011-11-29 Millennium Pharmaceuticals, Inc. Compounds useful as antagonists of CCR2
KR101176697B1 (ko) 2006-04-20 2012-08-23 에프. 호프만-라 로슈 아게 케모카인 수용체의 다이아제판 유도체 조절자
EP2123644B1 (en) 2007-03-07 2014-12-17 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
HUE034911T2 (hu) 2009-07-27 2018-03-28 Gilead Sciences Inc Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
AR080375A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
EP2588197B1 (en) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2012154760A1 (en) * 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
NO3175985T3 (cg-RX-API-DMAC7.html) 2011-07-01 2018-04-28
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
RU2726206C2 (ru) 2015-05-21 2020-07-09 Кемосентрикс, Инк. Модуляторы ccr2
EP3490992B1 (en) 2016-08-01 2023-03-22 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
PE20190501A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores nmda espiro-lactam y metodos de uso de los mismos
CA3031534C (en) 2016-08-01 2023-10-17 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
EP3687525B1 (en) 2017-09-25 2025-10-29 ChemoCentryx, Inc. Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor
CN112105353B (zh) 2018-01-08 2024-04-19 凯莫森特里克斯股份有限公司 Ccr2拮抗剂治疗实体瘤的方法
US20190269664A1 (en) 2018-01-08 2019-09-05 Chemocentryx, Inc. Methods of treating solid tumors with ccr2 antagonists
PE20210455A1 (es) 2018-01-31 2021-03-08 Aptinyx Inc Moduladores del receptor nmda espiro-lactama y usos de los mismos
CN111056955B (zh) * 2019-12-16 2021-05-25 中国科学院大连化学物理研究所 一种环己烯制备己二胺的方法
CN117342958B (zh) * 2023-09-12 2025-12-16 武汉理工大学 一种埋底界面材料及其制备得到的柔性钙钛矿太阳能电池

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013824A1 (en) * 2000-08-17 2002-02-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
CA2483843A1 (en) * 2002-04-29 2003-11-13 Merck & Co. Inc. Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
JP3780291B2 (ja) * 2002-04-29 2006-05-31 メルク エンド カムパニー インコーポレーテッド テトラヒドロピラニルシクロペンチルテトラヒドロピリドピリジン系のケモカイン受容体活性調節剤
CA2521625A1 (en) * 2003-04-17 2004-11-04 Merck & Co., Inc. Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

Similar Documents

Publication Publication Date Title
JP2006520783A5 (cg-RX-API-DMAC7.html)
JP6495868B2 (ja) キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用
RU2012138709A (ru) Производные арилметокси изоиндолина и композиции, включающие их, и способы их применения
WO2007069565A1 (ja) 二環式複素環化合物
MX2007005611A (es) Compuestos de imidazo[1,2-a]piridina, composiciones, usos y metodos relacionados.
JP2010515715A (ja) ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤としてのアミド置換インダゾール
CA3029611A1 (en) Combination comprising ep4 antagonist and immune checkpoint inhibitor
EP2669285A1 (en) Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
JP2008531468A5 (cg-RX-API-DMAC7.html)
EP2757884A1 (en) Pyrazolopyridyl compounds as aldosterone synthase inhibitors
JP2006523193A5 (cg-RX-API-DMAC7.html)
WO2008011109A3 (en) Substituted pyridone compounds and methods of use
JP2009114217A5 (cg-RX-API-DMAC7.html)
JP2018511616A (ja) 短鎖デヒドロゲナーゼ活性を調節する組成物および方法
WO2014017087A1 (ja) ピラゾロピリジン誘導体、またはその薬理学的に許容される塩
WO2011013651A1 (ja) 二環式化合物およびその医薬用途
PE20060609A1 (es) Derivados de quinuclidinas como antagonistas del receptor muscarinico (m3)
JP2014524441A (ja) 抗腫瘍剤としての三環式化合物
AR053548A1 (es) Derivados de oxiindol
JP2007511576A5 (cg-RX-API-DMAC7.html)
UY28961A1 (es) Derivados de ácido carboxílico de bencimidazolona antecedentes de la invención
JP2010155827A5 (cg-RX-API-DMAC7.html)
RU2005135432A (ru) Бензоксазинил*амидоциклопентил-гетероциклические модуляторы хемокиновых рецепторов
WO2013043518A1 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
JP2007518799A5 (cg-RX-API-DMAC7.html)